Seguici su acebook facebook Cerca nel sito:

Le ricerche di Gerona 2005

(17-01-13) Nutritional Intervention With Fish Oil Provides a Benefit Over Standard of Care for Weight and Skeletal Muscle Mass in Patients


Nutritional Intervention With Fish Oil Provides a Benefit Over Standard of Care for Weight and Skeletal Muscle Mass in Patients With Nonsmall Cell Lung Cancer Receiving Chemotherapy

Rachel A. Murphy, BSc1; Marina Mourtzakis, PhD2; Quincy S.C. Chu, MD3; Vickie E. Baracos, PhD3;
Tony Reiman, MD, SM4; and Vera C. Mazurak, PhD1
BACKGROUND: Involuntary weight loss is a major contributor to mortality and morbidity in patients with advanced
cancer. Nutritional intervention with fish oil (FO)-derived eicosapentaenoic acid (EPA) may prevent deterioration of
body composition. This study compared intervention with FO with standard of care (SOC; no intervention) with
regard to weight, skeletal muscle, and adipose tissue in newly referred patients with nonsmall cell lung cancer from
the time of initiation to completion of first-line chemotherapy. METHODS: Forty patients completed the study; there
were 16 in the FO group (dose of 2.2 g of EPA/day) and 24 patients in the SOC group. Skeletal muscle and adipose
tissue were measured using computed tomography images. Blood was collected and weight was recorded at baseline
and throughout chemotherapy. RESULTS: Patients in the SOC group experienced an average weight loss of 2.3 _
0.9 kg whereas patients receiving FO maintained their weight (0.5 _ 1.0 kg) (P ? .05). Patients with the greatest
increase in plasma EPA concentration after FO supplementation were found to have the greatest gains in muscle (r2
? 0.55; P ? .01). Approximately 69% of patients in the FO group gained or maintained muscle mass. Comparatively,
only 29% of patients in the SOC group maintained muscle mass, and overall the SOC group lost 1 kg of muscle. No
difference in total adipose tissue was observed between the 2 groups. CONCLUSIONS: Nutritional intervention with
2.2 g of FO per day appears to provide a benefit over SOC, resulting in the maintenance of weight and muscle mass
during chemotherapy.

Source: Cancer 2011;117:1775?82. VC 2011 American Cancer Society.

News

  • (30-08-2018) The electronics in fluorescent bulbs and light emitting diodes (LED), rather than ultraviolet radiation, cause increased malignant melanoma incidence in indoor office workers and tanning bed users

    Leggi tutto

  • (30-08-2018) Mitocondri e peso forma

    Leggi tutto

  • (29-08-2018) Stroke now impacting younger patients as a result of the obesity epidemic; 4 in 10 are now aged 40-69

    Leggi tutto

  • (29-08-2018) Perdere peso non vuol dire perdere osso!

    Leggi tutto

  • (29-08-2018) Brain cholesterol: long secret life behind a barrier.

    Leggi tutto

  • (29-08-2018) Stile di vita sano? Si può, basta usare la fantasia

    Leggi tutto

  • (22-08-2018) Top 10 medical treatments that can make you SICKER than before you took them

    Leggi tutto

  • (22-08-2018) Meno ansia - C’è una associazione tra dieta e disturbi mentali?

    Leggi tutto

  • (22-08-2018) Dietary curcumin supplementation attenuates inflammation, hepatic injury and oxidative damage in a rat model of intra-uterine growth retardation.

    Leggi tutto

  • (22-08-2018) Dopo la gravidanza - Una dieta a basso indice glicemico se serve perdere peso

    Leggi tutto

  • (21-08-2018) Sleep Disturbances Can Be Prospectively Observed in Patients with an Inactive Inflammatory Bowel Disease.

    Leggi tutto

  • (21-08-2018) Anche i neo-papà soffrono della depressione post partum

    Leggi tutto


In evidenza

"L'informazione presente nel sito serve a migliorare, e non a sostituire, il rapporto medico-paziente."

Per coloro che hanno problemi di salute si consiglia di consultare sempre il proprio medico curante.

Informazioni utili